Gainesville, FL, United States of America

Elia M Ayoub

This inventor holds 1 USPTO granted patent. Top assignee: University of Florida Research Foundation Inc.. Active years: 1990.


% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 12(Granted Patents)


Company Filing History:


Years Active: 1990

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Elia M Ayoub: Innovator in Immunology

Introduction

Elia M Ayoub is a notable inventor based in Gainesville, Florida. He has made significant contributions to the field of immunology through his innovative research and patents. His work focuses on the development of antigenic factors that have important applications in medical diagnostics.

Latest Patents

Elia M Ayoub holds a patent for a proteinaceous, antigenic factor derived from a group C Streptococcus. This factor serves as a receptor for the Fc region of IgG. The patent also includes a method for its preparation, as well as immunoassay and antigen detection methods employing the receptor. This invention has the potential to enhance diagnostic techniques in clinical settings.

Career Highlights

Ayoub is affiliated with the University of Florida Research Foundation, Incorporated. His role at this esteemed institution allows him to engage in cutting-edge research and collaborate with other experts in the field. His dedication to advancing immunological research is evident in his innovative contributions.

Collaborations

Elia M Ayoub has worked alongside notable colleagues, including Michael D Boyle and Kathleen J Reis. These collaborations have fostered a productive research environment, leading to advancements in their shared field of study.

Conclusion

Elia M Ayoub's contributions to immunology through his patent and research at the University of Florida Research Foundation highlight his role as an influential inventor. His work continues to pave the way for advancements in medical diagnostics and immunological research.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…